Magnetic Resonance Imaging in Acute Ischemic Stroke Treatment
Although intravenous administration of tissue plasminogen activator is the only proven treatment after acute ischemic stroke, there is always a concern of hemorrhagic risk after thrombolysis. Therefore, selection of patients with potential benefits in overcoming potential harms of thrombolysis is of...
Main Authors: | Bum Joon Kim, Hyun Goo Kang, Hye-Jin Kim, Sung-Ho Ahn, Na Young Kim, Steven Warach, Dong-Wha Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Stroke Society
2014-09-01
|
Series: | Journal of Stroke |
Subjects: | |
Online Access: | http://www.j-stroke.org/upload/pdf/jos-16-131.pdf |
Similar Items
-
Absence of July Phenomenon in Acute Ischemic Stroke Care Quality and Outcomes
by: Marco Gonzalez‐Castellon, et al.
Published: (2018-02-01) -
Intravenous thrombolysis in acute ischemic stroke
by: M. A. Domashenko, et al.
Published: (2017-02-01) -
Acute Reperfusion Therapies for Acute Ischemic Stroke
by: Rajeel Imran, et al.
Published: (2021-08-01) -
THE APPLICATION OF KINESIOTAPE IN THROMBOLIZED PATIENTS WITH ISCHEMIC STROKE
by: Mariela Filipova
Published: (2023-05-01) -
EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE
by: T. V. Demin, et al.
Published: (2010-03-01)